Lazard Asset Management
ASND icon

Lazard Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Lazard Asset Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,135
Closed -$8.35M – 1875
2025
Q4 		$8.35M Sell
39,135
-2,596
-6% -$536K 0.01% 441
2025
Q3 		$8.3M Sell
41,731
-10,897
-21% -$2.03M 0.01% 464
2025
Q2 		$9.08M Buy
52,628
+9,505
+22% +$1.55M 0.01% 570
2025
Q1 		$6.72M Buy
+43,123
New +$6.16M 0.01% 594
2021
Q4 		– Sell
-6,712
Closed -$1.07M – 2281
2021
Q3 		$1.07M Buy
+6,712
New +$919K ﹤0.01% 1054
2016
Q2 		– Sell
-193,050
Closed -$3.58M – 1043
2016
Q1 		$3.58M Hold
193,050
– – 0.01% 537
2015
Q4 		$3.54M Sell
193,050
-17,275
-8% -$303K 0.01% 563
2015
Q3 		$3.72M Hold
210,325
– – 0.01% 527
2015
Q2 		$3.7M Buy
210,325
+5,500
+3% +$96.2K 0.01% 569
2015
Q1 		$3.55M Buy
+204,825
New +$3.72M 0.01% 577

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management's ASND Position: Q1 2026 in Review

Lazard Asset Management sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 39,135 shares — an estimated $8.35M sold.

Lazard Asset Management first reported a position in ASND in Q1 2015 and held it in 10 quarters. The position peaked at $9.08M in Q2 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Lazard Asset Management reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 39,135 Ascendis Pharma A/S shares in Q1 2026, an estimated $8.35M.
  • Lazard Asset Management first reported a position in Ascendis Pharma A/S in Q1 2015 and held it in 10 quarters.
  • Lazard Asset Management's Ascendis Pharma A/S position peaked at $9.08M in Q2 2025.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.